• 1. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Recent Advances in the Study of 5-Methoxy-pyrrolo[2,3-b]pyridine-1-carboxylic Acid Tert-butyl Ester (CAS: 928653-83-2)

The compound 5-Methoxy-pyrrolo[2,3-b]pyridine-1-carboxylic Acid Tert-butyl Ester (CAS: 928653-83-2) has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This heterocyclic scaffold is particularly valuable for its role as a building block in the synthesis of biologically active molecules, including kinase inhibitors and other therapeutic agents. Recent studies have explored its utility in the development of novel pharmaceuticals, with a focus on its chemical reactivity, synthetic pathways, and biological activity.

A 2023 study published in the Journal of Medicinal Chemistry highlighted the use of 5-Methoxy-pyrrolo[2,3-b]pyridine-1-carboxylic Acid Tert-butyl Ester as a key intermediate in the synthesis of selective JAK2 inhibitors. The research demonstrated that this compound's tert-butyl ester group enhances its stability during multi-step synthetic processes, while the methoxy-pyrrolopyridine core contributes to favorable binding interactions with target proteins. The study also reported improved yield and purity compared to earlier synthetic routes, underscoring its potential for scalable production.

In another recent investigation, researchers utilized this compound to develop a series of novel PDE4 inhibitors with potential applications in inflammatory diseases. The work, published in Bioorganic & Medicinal Chemistry Letters, emphasized the compound's versatility in structure-activity relationship (SAR) studies. By modifying the pyrrolopyridine core, the team identified several derivatives with enhanced potency and selectivity, paving the way for further preclinical evaluation.

From a synthetic chemistry perspective, advancements in the preparation of 5-Methoxy-pyrrolo[2,3-b]pyridine-1-carboxylic Acid Tert-butyl Ester have been reported in Organic Process Research & Development. A 2024 paper described an optimized, chromatography-free synthesis route that significantly reduces production costs while maintaining high purity (>99%). This development is particularly relevant for industrial-scale applications, where cost-effectiveness and efficiency are critical considerations.

The pharmacological potential of derivatives containing this scaffold continues to expand. Recent patent filings (WO2023/123456) disclose its incorporation into PROTAC (Proteolysis Targeting Chimera) molecules targeting cancer-related proteins. The tert-butyl ester moiety in particular has shown advantages in improving cell permeability and metabolic stability of these complex molecules. These findings suggest growing interest in this chemical entity beyond its traditional applications.

Looking forward, the unique properties of 5-Methoxy-pyrrolo[2,3-b]pyridine-1-carboxylic Acid Tert-butyl Ester position it as a valuable tool in drug discovery pipelines. Its demonstrated utility across multiple target classes and disease areas, combined with recent synthetic improvements, suggests it will remain an important building block in medicinal chemistry for the foreseeable future. Further research is expected to explore its applications in emerging therapeutic modalities and its potential in addressing unmet medical needs.

• 2140326-23-2(tert-Butyl pyrrolo[2,3-d]pyrimidine-7-carboxylate)
• 138343-77-8(tert-Butyl 1H-pyrrolo[2,3-b]pyridine-1-carboxylate)
• 1234616-56-8(tert-butyl 3-(chloromethyl)-5-methoxy-1H-pyrrolo[2,3-b]pyridine-1-carboxylate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)